Correlation Between All Things and Shanrong Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both All Things and Shanrong Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining All Things and Shanrong Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between All Things Mobile and Shanrong Biotechnology Corp, you can compare the effects of market volatilities on All Things and Shanrong Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in All Things with a short position of Shanrong Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of All Things and Shanrong Biotechnology.

Diversification Opportunities for All Things and Shanrong Biotechnology

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between All and Shanrong is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding All Things Mobile and Shanrong Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanrong Biotechnology and All Things is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on All Things Mobile are associated (or correlated) with Shanrong Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanrong Biotechnology has no effect on the direction of All Things i.e., All Things and Shanrong Biotechnology go up and down completely randomly.

Pair Corralation between All Things and Shanrong Biotechnology

Given the investment horizon of 90 days All Things is expected to generate 1.73 times less return on investment than Shanrong Biotechnology. But when comparing it to its historical volatility, All Things Mobile is 1.53 times less risky than Shanrong Biotechnology. It trades about 0.02 of its potential returns per unit of risk. Shanrong Biotechnology Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  75.00  in Shanrong Biotechnology Corp on October 10, 2024 and sell it today you would lose (65.40) from holding Shanrong Biotechnology Corp or give up 87.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

All Things Mobile  vs.  Shanrong Biotechnology Corp

 Performance 
       Timeline  
All Things Mobile 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in All Things Mobile are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating primary indicators, All Things demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Shanrong Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shanrong Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

All Things and Shanrong Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with All Things and Shanrong Biotechnology

The main advantage of trading using opposite All Things and Shanrong Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if All Things position performs unexpectedly, Shanrong Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanrong Biotechnology will offset losses from the drop in Shanrong Biotechnology's long position.
The idea behind All Things Mobile and Shanrong Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance